O-GlcNAcylation刺激USP16的二基化活性,并调节细胞周期进展
Jianxin Zhao1, Jie Hua2, Yahui Zhan1
1Beijing Key Laboratory of DNA Damage Response and College of Life Science, Capital Normal University, Beijing, China.
The Journal of biological chemistry
|March 10, 2024
概括
在基因特异性化酶16 (USP16) 的O-关联的N-乙糖胺 (O-GlcNAc) 修改调节了其二基因化活性. 这种O-GlcNAcylation对于细胞循环的进展至关重要,因为它通过控制组织素和激酶的二维基因化.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 后翻译修改后的修改.
- 细胞周期调节细胞周期调节
背景情况:
- 基因表达的基因表达的关键表观遗传调节剂是2A单双基因基因表达 (uH2A).
- 乌比基因特异性化酶16 (USP16) 是负责去除H2A.H2A的双化酶.
- 与O相关的N-乙糖胺 (O-GlcNAc) 是一种动态的翻译后修饰,影响蛋白质功能和细胞过程.
研究的目的:
- 研究O-GlcNAcylation在调节USP16活动和功能的作用.
- 阐明USP16的O-GlcNAcylation如何影响其与基质的相互作用及其亚细胞局部化.
- 确定USP16 O-GlcNAcylation对细胞周期进展的功能影响.
主要方法:
- 使用化酶查确认USP16糖化位点 (Thr203和Ser214) 的发现.
- 位点定向突变发生,以评估O-GlcNAcylation位点突变对USP16活性的影响.
- 用酸化特异性抗体研究O-GlcNAcylation和酸化之间的相互作用.
- 细胞试验评估USP16在二基化H2AK119ub和Polo样酶中的作用 1.
主要成果:
- USP16是O-GlcNAcylated在Thr203和Ser214. 在Thr203和Ser214. 在Ser214.
- 对Thr203的突变降低了USP16的双化活性,而对Ser214的突变则产生了相反的效果.
- O-GlcNAcylation 对抗USP16的CDK1-介导酸化,并促进其核出口.
- USP16 O-GlcNAcylation 对于对Polo样酶1进行脱化至关重要,确保适当的染色体分离和细胞动力学.
结论:
- 在Thr203和Ser214中对USP16的O-GlcNAcylation是一种关键的调节机制.
- 这种修改协调了HU2A和Polo样酶1的二基化.
- USP16 O-GlcNAcylation通过精确控制关键基质,确保了适当的细胞循环进展.
更多相关视频
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
The Proteasome
833
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
833


